Written question asked by Pauline Latham (Conservative) on Tuesday, 21 July 2015, in the House of Commons. It was due for an answer on Monday, 7 September 2015 (named day). It was answered by George Freeman (Conservative) on Monday, 7 September 2015 on behalf of the Department of Health.
Nivolumab
- Question
-
To ask the Secretary of State for Health, what recent discussions he has had on the availability of nivolumab for melanoma patients through the Cancer Drugs Fund.
- Answer
-
We have had no such discussions.
NHS England is responsible for the operational management of the Cancer Drugs Fund. It has taken a decision not to consider new drugs like nivolumab, at this stage, whilst consideration is given to new ways of working and to ensure that the Fund remains within budget.
We understand that NHS England and the National Institute for Health and Care Excellence will shortly be consulting jointly on a proposed new system for commissioning cancer drugs.
The Government remains committed to the Fund which has so far helped over 72,000 people in England access the cancer drugs their doctors recommend for them.
Secondary information
- Type
- Written question
- Reference
- 8315
- Session
- 2015-16
- Subjects
- Skin cancer Nivolumab
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2016-07-05 20:08:15 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2015-16/8315
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2015-16/8315
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2015-16/8315